Otomo Susumu
Pharmacological Evaluation Laboratory, Taisho Pharmaceutical Co., Ltd., 403, Yoshino-cho 1-chome, Saitama-shi, Saitama 330-8530, Japan.
Nihon Yakurigaku Zasshi. 2002 Mar;119(3):167-74. doi: 10.1254/fpj.119.167.
The length and size of hair are depend on the anagen term in its hair cycle. It has been reported that the some cell growth factors, such as VEGF, FGF-5S, IGF-1 and KGF, induce the proliferation of cells in the matrix, dermal papilla and dermal papillary vascular system and increase the amount of extra cellular matrix in dermal papilla and then maintain follicles in the anagen phase. On the other hand, negative factors, like FGF-5, thrombospondin, or still unknown ones, terminate the anagen phase. If the negative factors become dominant against cell proliferation factors according to fulfilling some time set by the biological clock for hair follicles, TGF beta induced in the matrix tissues evokes apoptosis of matrix cells and shifts the follicles from anagen to catagen. Androgenetic alopecia is caused by miniaturizing of hair follicles located in the frontal or crown part of scalp and are hereditarily more sensitive to androgen. In their hair cycles, the androgen shortens the anagen phase of follicles and shifts them to the catagen phase earlier than usual. The mode of action of hair growth effect of minoxidil is not completely elucidated, but the most plausible explanation proposed here is that minoxidil works as a sulfonylurea receptor (SUR) activator and prolongs the anagen phase of hair follicles in the following manner: minoxidil (1) induces cell growth factors such as VEGF, HGF, IGF-1 and potentiates HGF and IGF-1 actions by the activation of uncoupled SUR on the plasma membrane of dermal papilla cells, (2) inhibits of TGF beta induced apoptosis of hair matrix cells by opening the Kir 6.0 channel pore coupled with SUR on the mitochondrial inner membrane, and (3) dilates hair follicle arteries and increases blood flow in dermal papilla by opening the Kir 6.0 channel pore coupled with SUR on the plasma membrane of vascular smooth muscle cells.
毛发的长度和大小取决于其毛发周期中的生长期。据报道,一些细胞生长因子,如血管内皮生长因子(VEGF)、成纤维细胞生长因子5S(FGF-5S)、胰岛素样生长因子1(IGF-1)和角质形成细胞生长因子(KGF),可诱导毛基质、毛乳头和毛乳头血管系统中的细胞增殖,并增加毛乳头中细胞外基质的量,从而使毛囊维持在生长期。另一方面,诸如成纤维细胞生长因子5(FGF-5)、血小板反应蛋白等负性因子,或一些仍未知的因子,则会终止生长期。如果根据毛囊生物钟设定的时间,负性因子相对于细胞增殖因子占主导地位,那么毛基质组织中诱导产生的转化生长因子β(TGFβ)会引发毛基质细胞凋亡,并使毛囊从生长期转变为退行期。雄激素性脱发是由位于头皮额部或顶部的毛囊小型化引起的,且遗传上对雄激素更为敏感。在其毛发周期中,雄激素会缩短毛囊的生长期,并使其比正常情况更早地进入退行期。米诺地尔生发作用的作用方式尚未完全阐明,但这里提出的最合理的解释是,米诺地尔作为磺酰脲受体(SUR)激活剂,以下列方式延长毛囊的生长期:米诺地尔(1)诱导VEGF、肝细胞生长因子(HGF)、IGF-1等细胞生长因子,并通过激活毛乳头细胞质膜上未偶联的SUR来增强HGF和IGF-1的作用;(2)通过打开线粒体内膜上与SUR偶联的内向整流钾通道6.0(Kir 6.0)孔道,抑制TGFβ诱导的毛基质细胞凋亡;(3)通过打开血管平滑肌细胞质膜上与SUR偶联的Kir 6.0孔道,扩张毛囊动脉并增加毛乳头中的血流量。